CRESCENT BIOPHARMA, INC.

SEC 4 · Filed

0001628280-26-044892Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 22, 2026

Sale by Pinkas Jan

Security
Ordinary Shares
Code
S
Shares
1,288
Price per share
17.99
Structured facts
{
  "code": "S",
  "date": "2026-06-22",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units granted to the Reporting Person on December 15, 2025. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on February 26, 2026, solely with the intent to cover taxes in connection with the vesting of the restricted stock units.",
    "F2": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.88 to $18.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."
  },
  "owners": [
    {
      "cik": "0002077126",
      "name": "Pinkas Jan",
      "roles": [
        "officer"
      ],
      "title": "Chief Scientific Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "22239",
  "price": "17.99",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Ordinary Shares",
  "shares": "1288",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}